Ginsenoside-Rh2 blocks the cell cycle of SK-HEP-1 cells at the G1/S boundary by selectively inducing the protein expression of p27(kip1)

Kwang Youl Lee*, Jeong Ae Park, Eunah Chung, You Hui Lee, Shin Il Kim, Seung Ki Lee

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

78 Scopus citations

Abstract

The mechanism of action by which ginsenoside-Rh2 (G-Rh2) suppresses the proliferation of SK-HEP-1 cells is reported. The results from flow cytometric analyses show that G-Rh2 arrested the cell cycle at the G1/S transition phase. The cyclin E-dependent kinase activity which had been immunoprecipitated with cyclin E-specific antibody was down-regulated in the cells in response to G-Rh2. The IC50 value required to down-regulate the kinase activity by 50% was approximately 0.75 μM. Immunoblotting analyses show that G-Rh2 selectively induced the expression of p27(kip1) in a dose-dependent manner whereas it had no effect on the levels of cyclin E, cdk2, and p21(WAF1). In addition, our data show that G-Rh2 reduced the protein levels of cdc25A at doses higher than 10 μM. Collectively, these data suggest that ginsenoside-Rh2 arrests the cell cycle at the G1/S transition phase by selectively inducing protein expression of p27(Kip1) and, as a consequence, down-regulating cyclin E-dependent kinase activity.

Original languageEnglish (US)
Pages (from-to)193-200
Number of pages8
JournalCancer Letters
Volume110
Issue number1-2
DOIs
StatePublished - Dec 20 1996

Keywords

  • Cyclin E-dependent kinase
  • Ginsenoside-Rh2
  • cdc25A
  • p27(Kip1)

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Ginsenoside-Rh2 blocks the cell cycle of SK-HEP-1 cells at the G1/S boundary by selectively inducing the protein expression of p27(kip1)'. Together they form a unique fingerprint.

Cite this